{"id":"https://openalex.org/W2560676754","doi":"https://doi.org/10.1182/blood.v116.21.2445.2445","title":"CXCL12 Enhances Survival of Chronic Lymphocytic Leukemia Cells Via a RAF-Dependent Pathway That Can Be Inhibited by Sorafenib","display_name":"CXCL12 Enhances Survival of Chronic Lymphocytic Leukemia Cells Via a RAF-Dependent Pathway That Can Be Inhibited by Sorafenib","publication_year":2010,"publication_date":"2010-11-19","ids":{"openalex":"https://openalex.org/W2560676754","doi":"https://doi.org/10.1182/blood.v116.21.2445.2445","mag":"2560676754"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v116.21.2445.2445","doi":"https://doi.org/10.1182/blood.v116.21.2445.2445","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.2445.2445","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080851422","display_name":"Davorka Messmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Davorka Messmer","raw_affiliation_strings":["Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108616747","display_name":"Jessie-F. Fecteau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jessie-F Fecteau","raw_affiliation_strings":["Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015043722","display_name":"Morgan O\u2019Hayre","orcid":"https://orcid.org/0000-0003-0965-7773","observed_orcids":["https://orcid.org/0000-0003-0965-7773"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Morgan O'Hayre","raw_affiliation_strings":["Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050290780","display_name":"Tracy M. Handel","orcid":"https://orcid.org/0000-0002-2558-6138","observed_orcids":["https://orcid.org/0000-0002-2558-6138"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tracy Handel","raw_affiliation_strings":["Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["Moores UCSD Cancer Center, The University of California, San Diego, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores UCSD Cancer Center, The University of California, San Diego, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5050290780","https://openalex.org/A5108616747"],"corresponding_institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1977,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.63038492,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"116","issue":"21","first_page":"2445","last_page":"2445"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cxcl12","display_name":"CXCL12","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sdf-1alpha","display_name":"SDF-1\u03b1","score":0.8299999833106995},{"id":"https://openalex.org/keywords/cxcr4","display_name":"CXCR4","score":0.7149999737739563},{"id":"https://openalex.org/keywords/zap-70","display_name":"ZAP-70","score":0.7590000033378601},{"id":"https://openalex.org/keywords/raf-signaling","display_name":"Raf signaling","score":0.7120000123977661},{"id":"https://openalex.org/keywords/mek-activation","display_name":"MEK activation","score":0.7480000257492065},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.8130000233650208},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9369999766349792},{"id":"https://openalex.org/keywords/gw5074","display_name":"GW5074","score":0.8539999723434448},{"id":"https://openalex.org/keywords/intracellular-calcium-flux","display_name":"intracellular calcium flux","score":0.8159999847412109},{"id":"https://openalex.org/keywords/cll-cell-survival","display_name":"CLL cell survival","score":0.7710000276565552},{"id":"https://openalex.org/keywords/nurse-like-cells","display_name":"nurse-like cells","score":0.7009999752044678},{"id":"https://openalex.org/keywords/stromal-microenvironment","display_name":"stromal microenvironment","score":0.7310000061988831},{"id":"https://openalex.org/keywords/chemokine-signaling","display_name":"chemokine signaling","score":0.671999990940094},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7369143962860107},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.6353296041488647},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6314593553543091},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.6024494767189026},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.47170400619506836},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4512532949447632},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.422954261302948},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.42162394523620605},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.410381019115448},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3807315230369568},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3268880844116211},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.30978256464004517},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28899943828582764},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.08987286686897278},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v116.21.2445.2445","doi":"https://doi.org/10.1182/blood.v116.21.2445.2445","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.2445.2445","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2055216141","https://openalex.org/W2560644535","https://openalex.org/W7100083032","https://openalex.org/W2591745349","https://openalex.org/W2522631801","https://openalex.org/W1566907430","https://openalex.org/W7099582084","https://openalex.org/W1905931638","https://openalex.org/W2560756697","https://openalex.org/W2311187111"],"abstract_inverted_index":{"Abstract":[0,1],"2445":[2],"The":[3,237,294],"cellular":[4],"microenvironment":[5,437],"is":[6,38,52,57,135],"critical":[7],"for":[8,104,147,206,389],"the":[9,43,100,124,203,420,432,436,449],"survival":[10,26,37,66,390,404],"of":[11,76,83,123,127,140,191,222,235,239,249,278,296,305,324,333,358,371,406,435,451,460],"Chronic":[12],"Lymphocytic":[13],"Leukemia":[14],"(CLL)":[15],"cells.":[16,176,397],"CLL":[17,35,77,96,115,138,166,175,179,198,320,359,363,381,396,408,439],"cells":[18,30,33,78,97,116,139,167,180,199,360,364,382,409],"die":[19],"rapidly":[20],"in":[21,39,95,164,173,209,256,318,391,430,448],"vitro":[22,392],"unless":[23],"they":[24],"receive":[25],"signals":[27],"from":[28],"stromal":[29,44],"or":[31,119],"\u201cnurse-like\u201d":[32],"(NLCs).":[34],"cell":[36],"part":[40],"mediated":[41],"by":[42,54,137,229,329,340,419],"cell-derived":[45],"factor-1":[46],"(SDF-1alpha,":[47],"designated":[48],"as":[49],"CXCL12),":[50],"which":[51,415],"expressed":[53,136],"NLCs.":[55],"CXCL12":[56,80,93,157,184,388,401],"a":[58,131,159,231,246,268,272,384,411],"highly":[59],"conserved":[60],"chemokine":[61],"that":[62,74,134,156,219,275,336,379,400,442],"can":[63,402,416],"promote":[64],"CLL-cell":[65,109],"through":[67,252],"its":[68,105],"receptor":[69],"CXCR4.":[70],"Prior":[71],"studies":[72],"showed":[73,365],"treatment":[75,450],"with":[79,117,186,374,453],"induced":[81,158],"activation":[82,208,317,323,353],"Extracellular":[84],"Signal-Regulated":[85],"Kinase":[86],"(ERK).":[87],"In":[88],"this":[89,112,443,454],"study,":[90],"we":[91,113,212,270,377],"examined":[92,114],"signaling":[94,251],"to":[98,107,183,196,258,368,387,462],"characterize":[99],"mechanism":[101,205],"(s)":[102],"accounting":[103],"ability":[106],"enhance":[108,403],"survival.":[110,153],"For":[111],"high-":[118],"low-":[120],"level":[121],"expression":[122],"zeta-associated":[125],"protein":[126],"70":[128],"kD":[129],"(ZAP-70),":[130],"tyrosine":[132],"kinase":[133,247,273,421],"patients":[141,452],"who":[142],"have":[143,446],"an":[144,303,331],"increased":[145,187],"risk":[146],"early":[148],"disease":[149],"progression":[150],"and":[151,188,193,217,224,254,262,265,283,286,307,311,346],"short":[152],"We":[154,398],"found":[155,218,287,378],"robust":[160],"intracellular":[161],"Ca2+":[162,171],"flux":[163,172],"ZAP-70+":[165,178,210,319,362,380,407],"but":[168,354],"only":[169,350],"modest-to-poor":[170],"ZAP-70-negative":[174,197,395],"Furthermore,":[177],"(n=10)":[181],"responded":[182],"stimulation":[185],"prolonged":[189],"phosphorylation":[190,221],"ERK":[192,223],"MEK":[194,207,225,292,316],"compared":[195],"(n=9).":[200],"To":[201],"investigate":[202],"underlying":[204],"CLL,":[211],"used":[213,271],"small":[214,232],"molecule":[215,233],"inhibitors":[216],"CXCL12-induced":[220,315,322],"could":[226,289,313,445],"be":[227,417,428],"blocked":[228],"sorafenib,":[230,341],"inhibitor":[234,248,274,304,332,422],"RAF.":[236],"role":[238],"RAF":[240,250,412],"was":[241,298,326],"further":[242,299],"supported":[243],"using":[244,301],"KG5,":[245],"B-RAF":[253,306],"C-RAF":[255,284],"addition":[257],"platelet-derived-growth-factor-receptor":[259],"(PDGFR)":[260],"alpha":[261],"beta,":[263],"Flt3,":[264,345],"Kit.":[266],"As":[267,424],"control,":[269],"targets":[276],"all":[277],"these":[279,375],"kinases":[280,335],"except":[281],"B-":[282],"(KG1)":[285],"it":[288],"not":[290,327,349],"inhibit":[291,314],"activation.":[293],"involvement":[295],"Raf":[297],"substantiated":[300],"GW5074,":[302],"C-RAF.":[308],"Both":[309],"KG5":[310],"GW5074":[312],"samples.":[321],"MEK/ERK":[325,352],"affected":[328],"sunitinib,":[330],"non-RAF":[334],"also":[337,355],"are":[338],"inhibited":[339,351],"including":[342],"VEGFR,":[343],"PDGFR,":[344],"c-Kit.":[347],"Sorafenib":[348],"caused":[356],"apoptosis":[357],"whereby":[361],"incresed":[366],"sensitivity":[367],"lower":[369],"doses":[370],"sorafenib.":[372,423],"Consistent":[373],"results":[376],"had":[383],"greater":[385],"responsiveness":[386],"than":[393],"did":[394],"conclude":[399],"particularly":[405],"via":[410],"dependent":[413],"pathway,":[414],"targeted":[418],"such,":[425],"sorafenib":[426],"might":[427],"effective":[429],"blocking":[431],"protective":[433],"influence":[434],"on":[438],"cells,":[440],"suggesting":[441],"drug":[444],"activity":[447],"disease.":[455],"Disclosures:":[456],"No":[457],"relevant":[458],"conflicts":[459],"interest":[461],"declare.":[463]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-12-16T00:00:00"}